# Female Orgasmic Disorder (FOD) and Wellbutrin XL

> **NCT00248209** · PHASE2,PHASE3 · COMPLETED · sponsor: **Segraves, R., T., M.D., Ph.D.** · enrollment: 48 (actual)

## Conditions studied

- Orgasmic Disorder

## Interventions

- **DRUG:** Wellbutrin XL

## Key facts

- **NCT ID:** NCT00248209
- **Lead sponsor:** Segraves, R., T., M.D., Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2011-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00248209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00248209, "Female Orgasmic Disorder (FOD) and Wellbutrin XL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00248209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*